Lawsuit Over Beyaz Generic Equivalent Filed by Bayer

feature photo

By: Staff Writers | Published: February 14th, 2012

Bayer has filed a lawsuit against Watson Pharmaceuticals for trying to sell a generic version of Beyaz, an updated formulation of the controversial Yaz and Yasmin birth control pills

Watson has been accused of patent infringement for trying to introduce its own generic version of Beyaz, a daily birth control pill containing estrogen, the “fourth generation” progestin drosperinone and a folate supplement.

According to the lawsuit over the Beyaz generic equivalent, Bayer claims to hold the exclusive right to the birth control pill until April 17, 2020. Compensatory and punitive damages are being sought against Watson, arguing that the generic drug maker should be hit with fines that are triple the amount of any revenue it may make from selling generic Beyaz.

Bayer obtained approval to market Beyaz in September 2010, adding a folate supplement to their blockbuster birth control pill Yaz, which became available as a generic that same year.

Yaz and Beyaz both combine 0.02 mg of ethinyl estradiol with 3 mg of drospirenone, a newer generation progestin, which was originally introduced in 2001 with Yasmin birth control, which combines 0.03 mg of ethinyl estradiol with the same 3 mg of drospirenone.

Bayer introduced Yaz in 2006, as the company began to face competition from generic Yasmin equivalents.

All of the drospirenone-based birth control pills have been marred by safety concerns in recent years, as studies suggest that the newer progestin may increase the risk of a blood clot, pulmonary embolism, deep vein thrombosis, stroke, heart attack or sudden death.

Bayer currently faces thousands of claims by women who have filed a Yaz lawsuit, Yasmin lawsuit or Beyaz lawsuit that alleges the drug maker failed to adequately research their birth control pills or warn about the risk of potentially life-threatening side effects.

The FDA recently released a report that suggested drospirenone-based birth control pills may increase the risk of blood clots by 75% over older birth control pills. They also doubled the risk of heart attacks and strokes in users who were new to birth control, with some health problems appearing in less than three months after women started to take the pills.

Tags: , , , , , , , , , , , , , , ,

There Is One Comment So Far • (Add Your Comments)

  1. While it is true there are a nuembr of women who (for whatever reason) do not take the pill as directed which indeed will greatly lower the pill’s efficacy I think there are times when it is appropriate to have the male go without a condom. In a committed long-term monogamous relationship (no moral tone is intended at all; it’s just MUCH easier to keep track of the pill-taking habits of only one partner!) where the woman religiously takes the pill and never ever misses it and it is always at the same time AND where she understands that there are certain drugs like antibiotics that can affect its efficacy, I think it’s totally acceptable not to use a second form of BC concurrent with the pill.Yes, there are a nuembr of women who (for whatever reason) are not as careful as this. And obviously if people have numerous partners, that adds another level of complexity to consider. But I really feel that in the example I cited, there is no reason for the man to also use a condom.Also, the articles you cite are twenty years old. Do you know of any that are more recent?Thanks for your perspective, though. I do agree (at least in many instances) that your suggestion is a wise one to follow for many people. Also, for those who aren’t 100% sure of a partner’s health, condoms will prevent the spread of a nuembr of STDs.

Post Your Comments

  • Share Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.
  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.